Cargando…
Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential
Atorvastatin, a favored option for hyperlipidemia exhibits the problem of poor gastric solubility and low absolute bioavailability (12%) along with higher pre-systemic clearance (>80%). Therefore, to circumvent these limitations, atorvastatin nanocrystals were prepared using poloxamer-188 as stab...
Autores principales: | Sharma, Manu, Mehta, Isha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834591/ https://www.ncbi.nlm.nih.gov/pubmed/31695118 http://dx.doi.org/10.1038/s41598-019-52645-0 |
Ejemplares similares
-
Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability
por: Zhao, Wenzheng, et al.
Publicado: (2023) -
Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
por: Tuomela, Annika, et al.
Publicado: (2016) -
Optimized zein nanospheres for improved oral bioavailability of atorvastatin
por: Hashem, Fahima M, et al.
Publicado: (2015) -
The Amorphous Solid Dispersion of Chrysin in Plasdone(®) S630 Demonstrates Improved Oral Bioavailability and Antihyperlipidemic Performance in Rats
por: Wang, Chenhui, et al.
Publicado: (2023) -
Systematic Development of Self-Emulsifying Drug Delivery Systems of Atorvastatin with Improved Bioavailability Potential
por: Khan, Fariba, et al.
Publicado: (2012)